NRx Pharmaceuticals, Inc. (NASDAQ:NRXPW) Short Interest Up 225.0% in November

NRx Pharmaceuticals, Inc. (NASDAQ:NRXPW) was the recipient of a large growth in short interest in November. As of November 30th, there was short interest totalling 3,900 shares, a growth of 225.0% from the November 15th total of 1,200 shares. Based on an average daily trading volume, of 4,900 shares, the days-to-cover ratio is presently 0.8 days.

NRx Pharmaceuticals Price Performance

NRXPW stock traded down $0.01 during midday trading on Wednesday, hitting $0.06. 2,780 shares of the company’s stock were exchanged, compared to its average volume of 15,709. The firm has a 50 day moving average price of $0.06 and a 200-day moving average price of $0.07. NRx Pharmaceuticals has a 12-month low of $0.04 and a 12-month high of $0.39.

NRx Pharmaceuticals Company Profile

NRx Pharmaceuticals, Inc, a clinical-stage biopharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders, including suicidal depression, post-traumatic stress disorder, and chronic pain. Its products include NRX-101 (D-cycloserine/Lurasidone), an oral, fixed dosed combination of D-cycloserine and lurasidone that earned FDA-designated breakthrough therapy for suicidal treatment-resistant bipolar depression; and NRX-100 (ketamine), which has been awarded FDA fast track designation for the treatment of severe bipolar depression with acute suicidal ideation and behavior.